Mirae Asset Global Investments Co. Ltd. Buys 3,440 Shares of The Cooper Companies, Inc. (NASDAQ:COO)

Mirae Asset Global Investments Co. Ltd. lifted its position in The Cooper Companies, Inc. (NASDAQ:COO - Free Report) by 15.1% during the 1st quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 26,189 shares of the medical device company's stock after purchasing an additional 3,440 shares during the quarter. Mirae Asset Global Investments Co. Ltd.'s holdings in Cooper Companies were worth $2,194,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently made changes to their positions in COO. Proficio Capital Partners LLC purchased a new stake in Cooper Companies in the fourth quarter valued at approximately $95,000. Smartleaf Asset Management LLC raised its position in shares of Cooper Companies by 55.5% during the 4th quarter. Smartleaf Asset Management LLC now owns 1,264 shares of the medical device company's stock valued at $116,000 after buying an additional 451 shares in the last quarter. Jones Financial Companies Lllp raised its position in shares of Cooper Companies by 227.7% during the 4th quarter. Jones Financial Companies Lllp now owns 970 shares of the medical device company's stock valued at $89,000 after buying an additional 674 shares in the last quarter. Steward Partners Investment Advisory LLC lifted its holdings in shares of Cooper Companies by 19.1% during the 4th quarter. Steward Partners Investment Advisory LLC now owns 1,407 shares of the medical device company's stock worth $129,000 after acquiring an additional 226 shares during the last quarter. Finally, Charles Schwab Investment Management Inc. grew its position in Cooper Companies by 3.1% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 1,151,654 shares of the medical device company's stock worth $105,872,000 after acquiring an additional 35,035 shares in the last quarter. Hedge funds and other institutional investors own 24.39% of the company's stock.

Cooper Companies Trading Down 0.0%

Cooper Companies stock traded down $0.01 during trading hours on Friday, reaching $73.01. The stock had a trading volume of 1,492,346 shares, compared to its average volume of 1,709,371. The company has a fifty day simple moving average of $75.78 and a 200-day simple moving average of $83.48. The Cooper Companies, Inc. has a 52 week low of $65.00 and a 52 week high of $112.38. The stock has a market cap of $14.60 billion, a PE ratio of 35.44, a PEG ratio of 1.78 and a beta of 0.99. The company has a debt-to-equity ratio of 0.30, a current ratio of 2.10 and a quick ratio of 1.23.

Cooper Companies (NASDAQ:COO - Get Free Report) last posted its earnings results on Thursday, May 29th. The medical device company reported $0.96 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.93 by $0.03. Cooper Companies had a return on equity of 9.60% and a net margin of 10.39%. The company had revenue of $1 billion for the quarter, compared to analysts' expectations of $995.12 million. During the same period last year, the firm earned $0.85 earnings per share. Cooper Companies's quarterly revenue was up 6.3% on a year-over-year basis. Analysts forecast that The Cooper Companies, Inc. will post 3.98 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

Several brokerages have issued reports on COO. Piper Sandler reaffirmed an "overweight" rating and set a $105.00 price target (down previously from $115.00) on shares of Cooper Companies in a research note on Friday, May 30th. Needham & Company LLC upgraded Cooper Companies from a "hold" rating to a "buy" rating and set a $94.00 target price for the company in a research report on Tuesday, June 17th. Wall Street Zen raised shares of Cooper Companies from a "hold" rating to a "buy" rating in a research note on Friday, June 27th. UBS Group raised shares of Cooper Companies to a "buy" rating in a report on Tuesday, June 17th. Finally, JPMorgan Chase & Co. reissued a "neutral" rating and issued a $76.00 price target (down from $110.00) on shares of Cooper Companies in a research note on Friday, May 30th. Three equities research analysts have rated the stock with a hold rating and nine have issued a buy rating to the company. Based on data from MarketBeat, Cooper Companies presently has an average rating of "Moderate Buy" and a consensus price target of $99.70.

About Cooper Companies

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.